Yuqian Tian

Yuqian Tian

Auto-generated profile, based on publicly available information

Yuqian Tian

University of Nebraska Medical Center

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2025 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Open access
ZBZachary M. Bauman
Zachary M. Bauman
YTYuqian Tian
Yuqian Tian
ADAndrew R. Doben
Andrew R. Doben
SSSebastian D. Schubl
Sebastian D. Schubl
FPFredric M. Pieracci
Fredric M. Pieracci
TWThomas W. White
Thomas W. White

1 January 2025
Verified
Book Chapter
Closed access
PDF file
YTYuqian Tian
Yuqian Tian
CBChristopher D. Barrett
Christopher D. Barrett
KKKevin M. Kemp
Kevin M. Kemp

17 July 2026 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
KNKristen D. Nordham
Kristen D. Nordham
DTDanielle Tatum
Danielle Tatum
MPMayur B. Patel
Mayur B. Patel
APAnil Paramesh
Anil Paramesh
LGLoren Gragert
Loren Gragert
STSharven Taghavi
Sharven Taghavi
BACKGROUND: One third of organ donors die due to catastrophic brain injury (CBI). CBI causes massive physiological derangements that can damage organs and prevent organ donation. Hormone replacement therapy (HRT) can mitigate this damage when given in the critical care setting, but no standardized protocol for use at trauma centers exists. Single-center studies show that HRT increases organ donation, but there has not been an investigation on which hormone combinations are most beneficial. METHODS: This prospective, observational EAST multicenter trial included adult CBI patients at 38 Level I and II trauma centers from January 2022 to June 2025. CBI was defined as a brain injury causing loss of function above the brain stem and subsequent death. A generalized linear mixed model analyzed the association of HRT and organ donation. RESULTS: Of 1,184 CBI patients, 704 received at least one hormone. There were 269 organ donors, and 227 received HRT. HRT patients were younger, more often male, sustained higher rates of penetrating brain injuries, and had lower rates of known comorbidities compared with non-HRT patients. HRT patients had higher ISS, but there was no difference in abbreviated injury scale-head scores between groups. GLMM analysis accounted for demographic and clinical differences between groups and found that single-hormone replacement with steroids, levothyroxine, vasopressin, dopamine, DDAVP, or insulin was associated with increased odds ratios of organ donation compared with no HRT. The combination of methylprednisolone and levothyroxine was associated with the greatest increased odds of donation. CONCLUSIONS: When administered to CBI patients before brain death, HRT is associated with significantly increased odds of organ donation. A standardized protocol incorporating HRT should be utilized across trauma centers to maximize organ donation in patients who have suffered nonsurvivable head trauma. ( J Trauma Acute Care Surg . 2026;101: 619–631.) LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level II.